SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-16-120184
Filing Date
2016-05-12
Accepted
2016-05-11 21:54:28
Documents
5
Period of Report
2016-05-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a16-10975_38k.htm 8-K 39284
2 EX-1.1 a16-10975_3ex1d1.htm EX-1.1 186841
3 EX-5.1 a16-10975_3ex5d1.htm EX-5.1 24721
4 EX-99.1 a16-10975_3ex99d1.htm EX-99.1 12111
5 GRAPHIC g109753kki001.jpg GRAPHIC 7913
  Complete submission text file 0001104659-16-120184.txt   275142
Mailing Address 281 TRESSER BOULEVARD, 9TH FLOOR STAMFORD CT 06901
Business Address 281 TRESSER BOULEVARD, 9TH FLOOR STAMFORD CT 06901 203-653-3880
Loxo Oncology, Inc. (Filer) CIK: 0001581720 (see all company filings)

IRS No.: 462996673 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36562 | Film No.: 161641487
SIC: 2834 Pharmaceutical Preparations